SEC Form 4 · accession 0001209191-15-080166
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 16, 2015 · 11:19 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 13, 2015 | P | 850 | $1.73 | A | 6,300 | D |
Table II — derivative securities
No Table II lines on this filing.